Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01392144 · ClinicalTrials.gov registry record
Phase II Evaluation of Exhaled Nitric Oxide (NO)
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 36
- Enrollment target
NCT01392144: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01392144 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01392144 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if the level of nitric oxide you breathe out may relate to the amount of breathing complications that you may experience due to radiation treatment.
Primary Outcome
Ratio between weekly and baseline nitric oxide measurements in participants receiving thoracic radiation therapy. Exhaled nitric oxide measured in triplicate on a weekly basis during radiotherapy and on each follow-up visit.
Interventions
- BEHAVIORAL Questionnaires
- PROCEDURE Nitric oxide breath test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-02 |
What the finished NCT01392144 record still lists
NCT01392144 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Questionnaires is the first listed.
NCT01392144 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01392144 about?
NCT01392144 is a clinical study titled "Phase II Evaluation of Exhaled Nitric Oxide (NO)". The goal of this clinical research study is to learn if the level of nitric oxide you breathe out may relate to the amount of breathing complications that you may experience due to radiation treatment.
What is the current status of trial NCT01392144?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2011-08. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01392144?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Nitric oxide breath test (PROCEDURE).
Who is sponsoring clinical trial NCT01392144?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia